Hls Therapeutics Inc opened trading today at $4.95 and closed at $4.75. It traded at a low of $4.60 to a high of $4.95.

Shares dipped -4.04 percent from the previous day's close of $4.95.

Today across North America, the TSX Composite closed tsx_percentage_change% at 21807.37, the S&P 500 closed sp_500_percentage_change% at 4967.23, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37986.40 and the Nasdaq Composite closed nasdaq_percentage_change% at 15282.01.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

Trading volume was 4,554 on 14 total trades. On average, Hls Therapeutics Inc has traded 3,612 shares over the last 5-days and 9,759 year-to-date.

The TSX market on the whole today saw 3,754 price advancers against 1,430 declines and 130 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, in the last 52 weeks, Hls Therapeutics Inc's shares have decreased -20.44%, while they have surged 20.25% this year.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $157.84 million on a float of 31,886 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Based on 5.00 analysts, Hls Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..